LOMA LINDA UNIVERSITY PATHOLOGY ME… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1986

Legal Domicile

Principal Officer

PAUL C HERRMANN MD

Phone

9095585170

Tax Period

2024-07-01 to 2025-06-30

LOMA LINDA UNIVERSITY PATHOLOGY MEDICAL GROUP INC, founded in 1986, is a community nonprofit in the Medical Research sector that reported $6.4M in total revenue in fiscal year 2024.

Mission

COORDINATION OF THE CLINICAL PRACTICE PROGRAM OF THE CLINICAL FACULTY OF THE PATHOLOGY DEPARTMENT OF THE LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE IN THEIR UNIVERSITY SPONSORED AND UNIVERSITY AUTHORIZED FACULTY PRACTICE ACTIVITY AND TO ENHANCE THEIR EDUCATION AND RESEARCH ENDEAVORS. THE PROMOTION OF HEALTH BY THE PERFORMANCE OF MEDICAL CARE SERVICES FOR THE PUBLIC WITHOUT PROFIT TO ANY INDIVIDUAL.

Program Service Accomplishments

Program 1

Expenses: $3,907,608 Revenue: $2,512,313

PATIENT CARE ACCOMPLISHMENT: 15,799 CLIENTS SERVED ($34,502 CHARITY CARE) ACTIVITY ACCOMPLISHMENT PROVIDED MEDICAL CARE TO ALL THE SICK AND INJURED WHO MAY COME FOR DIAGNOSIS, TREATMENT, AND CARE...

PATIENT CARE ACCOMPLISHMENT: 15,799 CLIENTS SERVED ($34,502 CHARITY CARE) ACTIVITY ACCOMPLISHMENT PROVIDED MEDICAL CARE TO ALL THE SICK AND INJURED WHO MAY COME FOR DIAGNOSIS, TREATMENT, AND CARE WITHOUT REGARD TO RACE, COLOR, CREED, SEX, AGE OR ABILITY TO PAY.

Program 2

Expenses: $2,069,449 Revenue: $31,515

TEACHING ACCOMPLISHMENT: PROVIDED PROFESSORS TO TEACH PATHOLOGY, IMMUNOLOGY, MICROBIOLOGY, RELIGION, HISTOLOGY, CELLULAR AND MOLECULAR BIOLOGY COURSES TO LLU SCHOOL OF MEDICINE AND LLU SCHOOL OF...

TEACHING ACCOMPLISHMENT: PROVIDED PROFESSORS TO TEACH PATHOLOGY, IMMUNOLOGY, MICROBIOLOGY, RELIGION, HISTOLOGY, CELLULAR AND MOLECULAR BIOLOGY COURSES TO LLU SCHOOL OF MEDICINE AND LLU SCHOOL OF ALLIED HEALTH FOR TRAINING DOCTORS, CYTOLOGIST, CLINICAL LABORATORY SCIENTISTS AND PATHOLOGISTS' ASSISTANTS. A TWO-DAY HYBRID SEMINAR TO 37 PARTICIPANTS WAS HOSTED.

Program 3

Expenses: $332,533 Revenue: $36,510

RESEARCH AND CTTR PROGRAM ACCOMPLISHMENT: THE CTTR PROGRAM HOSTED TWO SEPARATE SEMINARS TO 95 PARTICIPANTS; ACTIVITY OBJECTIVE - THE GROUP GIVES LECTURES AND PUBLISH INFORMATION CONCERNING...

RESEARCH AND CTTR PROGRAM ACCOMPLISHMENT: THE CTTR PROGRAM HOSTED TWO SEPARATE SEMINARS TO 95 PARTICIPANTS; ACTIVITY OBJECTIVE - THE GROUP GIVES LECTURES AND PUBLISH INFORMATION CONCERNING PATHOLOGICAL PROBLEMS AND RESEARCH RESULTS IN ORDER TO EDUCATE MEDICAL PROFESSIONALS ON SUCH PROBLEMS; THEY PUBLISHED 27 ABSTRACTS AND 22 PEER REVIEW ARTICLES IN MEDICAL JOURNALS; THEY PRESENTED 15 ABSTRACTS/CONFERENCE PRESENTATIONS WHICH WERE PEER REVIEWED AND 9 WHICH WERE NON-PEER REVIEWED; THEY PRESENTED 28 POSTERS AT CONFERENCES. THEY WROTE 2 BOOK CHAPTERS. THEY SERVED AS PRINCIPAL INVESTIGATORS ON 2 PROJECTS AND CO-INVESTIGATORS ON 1 PROJECT.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $3,629,451

Program Service Revenue $2,580,338

Investment Income $98,442

Other Revenue $53,623

TOTAL REVENUE $6,361,854

Expense Breakdown

Grants Paid $0

Salaries & Benefits $199,044

Fundraising Expenses $0

Program Expenses $6,309,590

Other Expenses $6,374,240

TOTAL EXPENSES $6,573,284

Year-over-Year Comparison

	2024	2023	Change
Revenue	$6,361,854	$6,186,790	+0.0%
Expenses	$6,573,284	$6,113,723	+0.1%
Net Income	$-211,430	$73,067	-3.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
TAMARA THOMAS MD	CHAIRPERSON	1.00	Director	$0	$0	$0
PAUL HERRMANN MD	DIRECTOR/PRESIDENT	1.00	Officer Director	$0	$0	$0
HEATHER ROJAS MD	DIRECTOR/SECRETARY	1.00	Officer Director	$0	$0	$0
DAVID HINSHAW MD	DIRECTOR	1.00	Director	$0	$0	$0
LEONARD WERNER	DIRECTOR	1.00	Director	$0	$0	$0
YAMIL LOPEZ MD	DIRECTOR/CFO	1.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$6,361,854	$6,573,284	$7,317,389	$-211,430
2024	$6,186,790	$6,113,723	$7,530,731	$73,067
2023	$7,299,360	$6,962,567	$7,430,702	$336,793
2022	$6,786,265	$6,729,590	$5,842,560	$56,675
2021	$6,447,784	$6,391,593	$5,605,075	$56,191
2020	$6,917,563	$6,881,134	$5,573,998	$36,429
2019	$7,306,559	$7,245,856	$6,350,163	$60,703
2018	$7,035,157	$6,599,146	$5,822,292	$436,011

LOMA LINDA UNIVERSITY PATHOLOGY MEDICAL GROUP INC